Dr. Martens plc

Informe acción LSE:DOCS

Capitalización de mercado: UK£748.4m

Dr. Martens Dirección

Dirección controles de criterios 4/4

El CEO de Dr. Martens' es Kenny Wilson , nombrado en Jul 2018, tiene una permanencia de 5.75 años. compensación anual total es £773.00K, compuesta por 93.3% salario y 6.7% primas, incluidas acciones y opciones de la empresa. posee directamente un 1.2% de las acciones de la empresa, por valor de £8.42M. La antigüedad media del equipo directivo y de la junta directiva es de 3.6 años y 3.3 años, respectivamente.

Información clave

Kenny Wilson

Chief Executive Officer (CEO)

UK£773.0k

Compensación total

Porcentaje del salario del CEO93.3%
Permanencia del CEO5.8yrs
Participación del CEO1.2%
Permanencia media de la dirección3.7yrs
Promedio de permanencia en la Junta Directiva3.3yrs

Actualizaciones recientes de la dirección

Recent updates

The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested

Mar 27
The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested

Dr. Martens (LON:DOCS) Has A Somewhat Strained Balance Sheet

Mar 06
Dr. Martens (LON:DOCS) Has A Somewhat Strained Balance Sheet

Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 57% Above Its Share Price

Feb 08
Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 57% Above Its Share Price

Dr. Martens plc's (LON:DOCS) Business And Shares Still Trailing The Market

Jan 21
Dr. Martens plc's (LON:DOCS) Business And Shares Still Trailing The Market

Dr. Martens' (LON:DOCS) Dividend Will Be £0.0156

Jan 03
Dr. Martens' (LON:DOCS) Dividend Will Be £0.0156

Dr. Martens (LON:DOCS) Will Pay A Dividend Of £0.0156

Dec 13
Dr. Martens (LON:DOCS) Will Pay A Dividend Of £0.0156

Dr. Martens (LON:DOCS) Is Very Good At Capital Allocation

Oct 12
Dr. Martens (LON:DOCS) Is Very Good At Capital Allocation

Calculating The Intrinsic Value Of Dr. Martens plc (LON:DOCS)

Sep 13
Calculating The Intrinsic Value Of Dr. Martens plc (LON:DOCS)

Returns on Capital Paint A Bright Future For Dr. Martens (LON:DOCS)

Jul 12
Returns on Capital Paint A Bright Future For Dr. Martens (LON:DOCS)

A Look At The Intrinsic Value Of Dr. Martens plc (LON:DOCS)

Jun 02
A Look At The Intrinsic Value Of Dr. Martens plc (LON:DOCS)

Dr. Martens (LON:DOCS) Is Investing Its Capital With Increasing Efficiency

Feb 25
Dr. Martens (LON:DOCS) Is Investing Its Capital With Increasing Efficiency

Is There An Opportunity With Dr. Martens plc's (LON:DOCS) 34% Undervaluation?

Dec 17
Is There An Opportunity With Dr. Martens plc's (LON:DOCS) 34% Undervaluation?

The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested

Oct 02
The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested

Dr. Martens (LON:DOCS) Knows How To Allocate Capital Effectively

Jul 04
Dr. Martens (LON:DOCS) Knows How To Allocate Capital Effectively

Why Investors Shouldn't Be Surprised By Dr. Martens plc's (LON:DOCS) 26% Share Price Surge

Jun 16
Why Investors Shouldn't Be Surprised By Dr. Martens plc's (LON:DOCS) 26% Share Price Surge

Are Investors Undervaluing Dr. Martens plc (LON:DOCS) By 27%?

Mar 02
Are Investors Undervaluing Dr. Martens plc (LON:DOCS) By 27%?

Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 19% Below Its Share Price

Dec 01
Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 19% Below Its Share Price

Are Dr. Martens plc (LON:DOCS) Investors Paying Above The Intrinsic Value?

Aug 24
Are Dr. Martens plc (LON:DOCS) Investors Paying Above The Intrinsic Value?

Investors Can Find Comfort In Dr. Martens' (LON:DOCS) Earnings Quality

Jun 24
Investors Can Find Comfort In Dr. Martens' (LON:DOCS) Earnings Quality

Does This Valuation Of Dr. Martens plc (LON:DOCS) Imply Investors Are Overpaying?

Apr 29
Does This Valuation Of Dr. Martens plc (LON:DOCS) Imply Investors Are Overpaying?

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Kenny Wilson en comparación con los beneficios de Dr. Martens?
FechaCompensación totalSalarioIngresos de la empresa
Sep 30 2023n/an/a

UK£103m

Jun 30 2023n/an/a

UK£116m

Mar 31 2023UK£773kUK£721k

UK£129m

Dec 31 2022n/an/a

UK£153m

Sep 30 2022n/an/a

UK£177m

Jun 30 2022n/an/a

UK£179m

Mar 31 2022UK£2mUK£700k

UK£181m

Dec 31 2021n/an/a

UK£118m

Sep 30 2021n/an/a

UK£54m

Jun 30 2021n/an/a

UK£44m

Mar 31 2021UK£815kUK£118k

UK£35m

Compensación vs. Mercado: La compensación total ($USD966.84K) de Kenny está en línea con el promedio de empresas de tamaño similar en el mercado UK ($USD1.32M).

Compensación vs. Ingresos: La compensación de Kenny ha sido consistente con los resultados de la empresa en el último año.


CEO

Kenny Wilson (57 yo)

5.8yrs

Permanencia

UK£773,000

Compensación

Mr. Kenneth Wilson, also known as Kenny, is Chief Executive Officer at Dr. Martens Limited and Dr. Martens plc since July 2018 and serves as its Director since January 5, 2021. He joined Dr. Martens Limite...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Kenneth Wilson
CEO & Director5.8yrsUK£773.00k1.2%
£ 9.0m
Jon Mortimore
CFO & Director8.1yrsUK£503.00k0%
£ 0
Onyeije Nwokorie
Chief Brand Officerless than a yearUK£67.00k0%
£ 0
Geert Peeters
Chief Operating Officer5.9yrssin datossin datos
Ronald Garricks
Chief Information Officer4.1yrssin datossin datos
Meg Johnson
Chief Marketing Officer2.1yrssin datossin datos
Emily Reichwald
Chief People & Sustainability Officer and Company Secretary3.3yrssin datossin datos
Sean O'Neill
Chief Digital Officer6.1yrssin datossin datos
Derek Chan
President of APAC4.7yrssin datossin datos
Adam Meek
Chief Product Officer2.4yrssin datossin datos
Jennifer Somer
President of Americas2.5yrssin datossin datos
Mike Stopforth
President of EMEAless than a yearsin datossin datos

3.7yrs

Permanencia media

56yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de DOCS se considera experimentado (3.6 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Kenneth Wilson
CEO & Director3.3yrsUK£773.00k1.2%
£ 9.0m
Jon Mortimore
CFO & Director3.6yrsUK£503.00k0%
£ 0
Andrew Harrison
Independent Non-Executive Directorless than a yearsin datos0.0019%
£ 14.3k
Ian Rogers
Independent Non-Executive Director3.3yrsUK£67.00k0.0021%
£ 15.8k
Robyn Perriss
Independent Non-Executive Director3.3yrsUK£94.00k0.010%
£ 77.3k
Tara Alhadeff
Representative Non-Independent Non-Executive Director3.3yrssin datossin datos
Lynne Weedall
Senior Independent Non-Executive Director3.3yrsUK£99.00k0.0022%
£ 16.4k
Paul Mason
Chair of the Board8.7yrsUK£335.00k0.82%
£ 6.1m

3.3yrs

Permanencia media

56yo

Promedio de edad

Junta con experiencia: La junta directiva de DOCS se considera experimentada (3.3 años de antigüedad promedio).